Burkitt Lymphoma

Burkitt Lymphoma is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as: Burkitt's Lymphoma · Burkitt Lymphoma (BL)
Classified under: Hemic and Lymphatic Diseases
Immunoproliferative Disorders
Infections
Lymphatic Disorders
Neoplasms
Indicated drugs: Cyclophosphamide

Resolves to

Vocabularies

MeSHM0003058ICD-10C83.7SNOMED CT118617000MedDRA10006596UMLSC0006413

What you can answer from here — as of October 31, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

887Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Burkitt Lymphoma share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.